- Recommendation ID
- DG41/1
- Question
Further research is recommended to assess the diagnostic yield of the BioMonitor 2‑AF and Confirm Rx (or later devices) for atrial fibrillation when used in people who have had a cryptogenic stroke. The committee noted that existing ongoing research may provide further data for these devices (see section 3.51 and section 4.19).
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke
- Number
- DG41
- Date issued
- September 2020
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 26/08/2020 |